title: Management of the oral and maxillofacial surgery patient on anabolic steroids.
abstract: Recent Food and Drug Administration estimates indicate that the anabolic steroid market has reached the $100 million level. Although the news media report steroid-related deaths, there is little in the medical literature communicating the clinical implications concerning these drugs. Electrolyte disturbances, coagulopathies, hypertension, and dysrhythmias are a few of the potential side effects. The pharmacology and pathophysiology of anabolic steroids are presented with a discussion of the anesthetic and surgical concerns for the patient undergoing oral and maxillofacial surgery.
authors.affiliation: Division of Oral and Maxillofacial Surgery, Cleveland Metropolitan General Hospital, OH 44109.
authors.forename: B K
authors.initials: BK
authors.lastname: Smith
authors.forename: R H
authors.initials: RH
authors.lastname: Haug
authors.forename: L
authors.initials: L
authors.lastname: Shepard
authors.forename: A T
authors.initials: AT
authors.lastname: Indresano
mesh_terms: D045930:Anabolic Agents / Q000494:pharmacology; D000758:Anesthesia; D005145:Face / Q000601:surgery*; D006801:Humans; D056948:Orthognathic Surgical Procedures
chemical_list: D045930:Anabolic Agents